Temasek said in a statement last week that it would take part in a Singapore-government developed program which will "catalyse patient growth capital" of up to S$1.5 billion for Singaporean companies, by co-investing with the private sector.Temasek, through a whole-owned subsidiary called Heliconia Capital Management, will manage the first phase of the program. Full story
